Botanical species · safety record

Artemisia capillaris

The EFSA Compendium of Botanicals holds 7 constituent measurements, 1 adverse-effect record and 2 genotoxicity assays for Artemisia capillaris. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Artemisia capillaris Thunb.

7Constituent measurements

3Safety records

6Cited sources

125Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 125 licensed products naming Artemisia capillaris as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
solid

Source material stated

Aerial parts
Herb
Herb top
Herba
Leaf
Leaf bud
New material
Rhizome

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Coumarins	Live plants	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Scoparone	Shoot	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
1,8-cineole	Flower	Essential oil	≤ 1.3 Percent	GC-MS	No resolvable identifier
Acenaphthylene	Leaves	Solvent extraction	37.91 Percent	GC-MS	No resolvable identifier
Coumarins	Aerial part of plants	—	—	Unspecified	No resolvable identifier
Eugenol	Flower	Essential oil	≤ 15 Percent	GC-MS	No resolvable identifier
Eugenol	Flower	Essential oil	≥ 4.3 Percent	GC-MS	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Live plants	Solvent extraction	—	In vitro	Resolve DOI

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

Outcome	Endpoint	Test	Tested organism	Metabolic activation	Source
Positive	DNA damage and/or repair	micronucleus assay	House mouse (as animal)	Not applicable	No resolvable identifier
Positive	chromosome aberration	chromosome aberration assay	House mouse (as animal)	Not applicable	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

YIN, XJ., LIU, DX., WANG, HC., ZHOU, Y. A STUDY ON THE MUTAGENICITY OF 102 RAW PHARMACEUTICALS USED IN CHINESE TRADITIONAL MEDICINE. MUTATION RESEARCH, 1991, vol. 260, no. 1, p. 73-82.
Jang, SI., Kim, YJ., Lee, WY., Kwak, KC., Baek, SH., Kwak, GB., Yun, YG., Kwon, TO., Chung, HT., Chai, KY. Scoparone from Artemisia capillaris inhibits the release of inflammatory mediators in RAW 264.7 cells upon stimulation cells by interferon-gamma plus LPS. ARCHIVES OF PHARMACAL RESEARCH, 2005, vol. 28, no. 2, p. 203-208. DOI
Islam, Md Nurul., Jung, Hyun Ah., Sohn, Hee Sook., Kim, Hye Mi., Choi, Jae Sue. Potent alpha-glucosidase and protein tyrosine phosphatase 1B inhibitors from Artemisia capillaris . Archives of pharmacal research, 2013, vol. 36, no. 5, p. 542-552. DOI
Verma, R. S., Laiq-ur-Rahman., Verma, R. K., Chauhan, Amit., Singh, Anand., Chanotiya, C. S., Yadav, Anju., Singh, A. K., Kukreja, A. K., Khanuja, S. P. S. Essential Oil Composition of the Inflorescence of Artemisia capillaris Thunb. Collected at Different Stages of Flowering from Kumaon Region of Western Himalaya . Journal of essential oil research, 2010, vol. 22, no. 4, p. 340-343.
Yun, KyeongWon. Phytotoxicity and Volatile Monoterpenes of Leaves from Artemisia capillaris and Artemisia iwayomogi Used as Korean Herbal Injin. Journal of Ecology and Environment, 2009, vol. 32, no. 1, p. 9-12.
Kostova, I., Raleva, S., Genova, P., Argirova, R. Recent advances in the discovery and development of plant-derived natural coumarins and their analogues as anti human immunodeficiency virus - Type 1 (HIV-1) agents. Biotechnology and Biotechnological Equipment, 2005, vol. 19, no. 1, p. 16-22.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature